Transcriptome-directed Analysis for Mendelian Disease Diagnosis Overcomes Limitations of Conventional Genomic Testing

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2020 Oct 1

PMID 33001864

Citations 59

Authors

David R Murdock

Hongzheng Dai

Lindsay C Burrage

Jill A Rosenfeld

Shamika Ketkar

Michaela F Muller

Vicente A Yepez

Julien Gagneur

Pengfei Liu

Shan Chen

Mahim Jain

Gladys Zapata

Carlos A Bacino

Hsiao-Tuan Chao

Paolo Moretti

William J Craigen

Neil A Hanchard

Brendan Lee

Affiliations

Soon will be listed here.

Abstract

BACKGROUNDTranscriptome sequencing (RNA-seq) improves diagnostic rates in individuals with suspected Mendelian conditions to varying degrees, primarily by directing the prioritization of candidate DNA variants identified on exome or genome sequencing (ES/GS). Here we implemented an RNA-seq-guided method to diagnose individuals across a wide range of ages and clinical phenotypes.METHODSOne hundred fifteen undiagnosed adult and pediatric patients with diverse phenotypes and 67 family members (182 total individuals) underwent RNA-seq from whole blood and skin fibroblasts at the Baylor College of Medicine (BCM) Undiagnosed Diseases Network clinical site from 2014 to 2020. We implemented a workflow to detect outliers in gene expression and splicing for cases that remained undiagnosed despite standard genomic and transcriptomic analysis.RESULTSThe transcriptome-directed approach resulted in a diagnostic rate of 12% across the entire cohort, or 17% after excluding cases solved on ES/GS alone. Newly diagnosed conditions included Koolen-de Vries syndrome (KANSL1), Renpenning syndrome (PQBP1), TBCK-associated encephalopathy, NSD2- and CLTC-related intellectual disability, and others, all with negative conventional genomic testing, including ES and chromosomal microarray (CMA). Skin fibroblasts exhibited higher and more consistent expression of clinically relevant genes than whole blood. In solved cases with RNA-seq from both tissues, the causative defect was missed in blood in half the cases but none from fibroblasts.CONCLUSIONSFor our cohort of undiagnosed individuals with suspected Mendelian conditions, transcriptome-directed genomic analysis facilitated diagnoses, primarily through the identification of variants missed on ES and CMA.TRIAL REGISTRATIONNot applicable.FUNDINGNIH Common Fund, BCM Intellectual and Developmental Disabilities Research Center, Eunice Kennedy Shriver National Institute of Child Health & Human Development.

Citing Articles

Shaping the future of care for patients with Ehlers-Danlos syndromes: from multidisciplinary management to precision medicine.

Xu K, Li G, Zhang T, Wu N Orphanet J Rare Dis. 2025; 20(1):98.

PMID: 40033344 PMC: 11877729. DOI: 10.1186/s13023-025-03615-5.

MAJIQ-CLIN: A novel tool for the identification of Mendelian disease-causing variants from RNA-Seq data.

Aicher J, Issakova D, Slaff B, Jewell S, Lahens N, Grant G medRxiv. 2025; .

PMID: 39974028 PMC: 11838695. DOI: 10.1101/2025.01.30.25321185.

Transcriptome-wide outlier approach identifies individuals with minor spliceopathies.

Arriaga M, Mendez R, Ungar R, Bonner D, Matalon D, Lemire G medRxiv. 2025; .

PMID: 39802771 PMC: 11722475. DOI: 10.1101/2025.01.02.24318941.

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity.

Hirschi O, Felker S, Rednam S, Vallance K, Parsons D, Roy A Genet Med Open. 2024; 2():101850.

PMID: 39669609 PMC: 11613871. DOI: 10.1016/j.gimo.2024.101850.

Long-read RNA sequencing: A transformative technology for exploring transcriptome complexity in human diseases.

Ament I, DeBruyne N, Wang F, Lin L Mol Ther. 2024; 33(3):883-894.

PMID: 39563027 PMC: 11897757. DOI: 10.1016/j.ymthe.2024.11.025.

References

Moles-Fernandez A, Duran-Lozano L, Montalban G, Bonache S, Lopez-Perolio I, Menendez M . Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?. Front Genet. 2018; 9:366. PMC: 6134256. DOI: 10.3389/fgene.2018.00366. View

Tucker T, Zahir F, Griffith M, Delaney A, Chai D, Tsang E . Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes. Eur J Hum Genet. 2013; 22(6):792-800. PMC: 4023222. DOI: 10.1038/ejhg.2013.248. View

Derar N, Al-Hassnan Z, Al-Owain M, Monies D, Abouelhoda M, Meyer B . De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype. Genet Med. 2018; 21(1):185-188. DOI: 10.1038/s41436-018-0014-8. View

Robinson J, Thorvaldsdottir H, Wenger A, Zehir A, Mesirov J . Variant Review with the Integrative Genomics Viewer. Cancer Res. 2017; 77(21):e31-e34. PMC: 5678989. DOI: 10.1158/0008-5472.CAN-17-0337. View

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

Gonorazky H, Naumenko S, Ramani A, Nelakuditi V, Mashouri P, Wang P . Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease. Am J Hum Genet. 2019; 104(5):1007. PMC: 6507041. DOI: 10.1016/j.ajhg.2019.04.004. View

DeMari J, Mroske C, Tang S, Nimeh J, Miller R, Lebel R . CLTC as a clinically novel gene associated with multiple malformations and developmental delay. Am J Med Genet A. 2016; 170A(4):958-66. DOI: 10.1002/ajmg.a.37506. View

Retterer K, Scuffins J, Schmidt D, Lewis R, Pineda-Alvarez D, Stafford A . Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort. Genet Med. 2014; 17(8):623-9. DOI: 10.1038/gim.2014.160. View

Koolen D, Pfundt R, Linda K, Beunders G, Veenstra-Knol H, Conta J . The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. Eur J Hum Genet. 2015; 24(5):652-9. PMC: 4930086. DOI: 10.1038/ejhg.2015.178. View

10.

Nabais Sa M, Venselaar H, Wiel L, Trimouille A, Lasseaux E, Naudion S . De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy. Genet Med. 2019; 22(4):797-802. DOI: 10.1038/s41436-019-0703-y. View

11.

Le C, Prasad A, Rupar C, Debicki D, Andrade A, Prasad C . Infantile-Onset Multisystem Neurologic, Endocrine, and Pancreatic Disease: Case and Review. Can J Neurol Sci. 2019; 46(4):459-463. DOI: 10.1017/cjn.2019.35. View

12.

Firth H, Richards S, Bevan A, Clayton S, Corpas M, Rajan D . DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009; 84(4):524-33. PMC: 2667985. DOI: 10.1016/j.ajhg.2009.03.010. View

13.

Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T . GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017; 2017. PMC: 5467550. DOI: 10.1093/database/bax028. View

14.

Koolen D, Vissers L, Pfundt R, de Leeuw N, Knight S, Regan R . A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet. 2006; 38(9):999-1001. DOI: 10.1038/ng1853. View

15.

Karam R, Conner B, LaDuca H, McGoldrick K, Krempely K, Richardson M . Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer. JAMA Netw Open. 2019; 2(10):e1913900. PMC: 6820040. DOI: 10.1001/jamanetworkopen.2019.13900. View

16.

Mertes C, Scheller I, Yepez V, Celik M, Liang Y, Kremer L . Detection of aberrant splicing events in RNA-seq data using FRASER. Nat Commun. 2021; 12(1):529. PMC: 7822922. DOI: 10.1038/s41467-020-20573-7. View

17.

Amberger J, Bocchini C, Schiettecatte F, Scott A, Hamosh A . OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2014; 43(Database issue):D789-98. PMC: 4383985. DOI: 10.1093/nar/gku1205. View

18.

Rehm H, Berg J, Brooks L, Bustamante C, Evans J, Landrum M . ClinGen--the Clinical Genome Resource. N Engl J Med. 2015; 372(23):2235-42. PMC: 4474187. DOI: 10.1056/NEJMsr1406261. View

19.

Landrum M, Lee J, Benson M, Brown G, Chao C, Chitipiralla S . ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2015; 44(D1):D862-8. PMC: 4702865. DOI: 10.1093/nar/gkv1222. View

20.

Yang Y, Muzny D, Xia F, Niu Z, Person R, Ding Y . Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014; 312(18):1870-9. PMC: 4326249. DOI: 10.1001/jama.2014.14601. View